These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36871872)

  • 1. Time to intestinal clearance of carbapenemase-producing Enterobacterales in hospital patients: a longitudinal retrospective observational cohort study.
    Henoun Loukili N; Loquet A; Perrin A; Gaillot O; Bruandet A; Sendid B; Zahar JR; Nseir S
    J Hosp Infect; 2023 May; 135():4-10. PubMed ID: 36871872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical outcomes of patients with serial negative surveillance cultures according to a subsequent polymerase chain reaction test for carbapenemase-producing Enterobacterales.
    Seo H; Kim S; Lee YW; Oh HS; Kim HS; Kim YK
    J Hosp Infect; 2024 Apr; 146():93-101. PubMed ID: 38369061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Genomic Characterization of Carbapenemase-producing Enterobacteriaceae (CPE) Reveals Changing Pattern of CPE Isolated in Hong Kong Hospitals.
    Zhu C; Li C; Lai CKC; Ng R; Chau KY; Wong KT; Lo NWS; Barua N; Yang Y; Liyanapathirana V; Hui M; Lai RW; Fung KSC; Tsang DN; Ip M
    Int J Antimicrob Agents; 2021 Nov; 58(5):106430. PubMed ID: 34525401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of carbapenemase-producing Enterobacterales intestinal colonisation in the elderly population after hospital discharge, Italy, 2018-2020.
    Tinelli M; Rossini A; Scudeller L; Zabzuni D; Errico G; Fogato E; D'Angelo R; Gentiloni Silverj F; Cesana E; Bergamaschini LC; Pasi F; Monaco M; Cerquetti M; Pantosti A; Giufrè M
    Int J Antimicrob Agents; 2022 Jun; 59(6):106594. PubMed ID: 35483624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Israeli national policy for discontinuation of isolation of carbapenem-resistant Enterobacterales carriers by carbapenemase type: a retrospective cohort study.
    Dickstein Y; Solter E; Schwartz D; Nutman A; Harevrich I; Wulffhart L; Carmeli Y; Schwaber MJ
    Clin Microbiol Infect; 2021 Oct; 27(10):1518.e1-1518.e3. PubMed ID: 34111587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Carriage of Extended-Spectrum β-Lactamase and Carbapenemase-Producing Enterobacterales Strains in Patients with Colorectal Cancer in the Oncology Unit of Amizour Hospital, Algeria: A Prospective Cohort Study.
    Touati A; Talbi M; Mairi A; Messis A; Adjebli A; Louardiane M; Lavigne JP
    Microb Drug Resist; 2020 Nov; 26(11):1383-1389. PubMed ID: 32181693
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Time-to-Onset of Carbapenemase-Producing Enterobacterales (CPE) Infections in CPE Carriers: a Retrospective Cohort Study.
    Hoellinger B; Deboscker S; Danion F; Lavigne T; Severac F; Ruch Y; Ursenbach A; Lefebvre N; Boyer P; Hansmann Y
    Microbiol Spectr; 2022 Dec; 10(6):e0186822. PubMed ID: 36321906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of contact isolation strategy for the containment of extended-spectrum β-lactamase carriers in a University Hospital positively affects the epidemiology of carbapenemase-producing Enterobacterales.
    Hernández-García M; Díaz-Agero C; Pérez-Viso B; Sánchez AM; López-Fresneña N; Morosini MI; Ruiz-Garbajosa P; Cantón R
    Enferm Infecc Microbiol Clin (Engl Ed); 2021 Nov; 39(9):429-435. PubMed ID: 34736747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE.
    Lim YJ; Park HY; Lee JY; Kwak SH; Kim MN; Sung H; Kim SH; Choi SH
    Clin Microbiol Infect; 2018 Oct; 24(10):1104.e5-1104.e8. PubMed ID: 29870856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016.
    van den Bunt G; van Pelt W; Hidalgo L; Scharringa J; de Greeff SC; Schürch AC; Mughini-Gras L; Bonten MJM; Fluit AC
    Euro Surveill; 2019 Oct; 24(41):. PubMed ID: 31615600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics of and Risk Factors for Subsequent Carbapenemase-producing Enterobacterales (CPE) Bacteraemia in Rectal CPE Carriers.
    Kang SW; Park S; Kim AR; Han J; Lee J; Seo H; Sung H; Kim MN; Chang E; Bae S; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Kim YS; Song EH; Chong YP
    Int J Antimicrob Agents; 2023 Nov; 62(5):106959. PubMed ID: 37633425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissemination of carbapenemase-producing Enterobacterales in the community of Rawalpindi, Pakistan.
    Habib A; Lo S; Villageois-Tran K; Petitjean M; Malik SA; Armand-Lefèvre L; Ruppé E; Zahra R
    PLoS One; 2022; 17(7):e0270707. PubMed ID: 35802735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbapenemase-producing Eenterobacterales from hospital environment and their relation to those from patient specimens.
    Kim SH; Kim GR; Kim EY; Jeong J; Kim S; Shin JH
    J Infect Public Health; 2022 Feb; 15(2):241-244. PubMed ID: 35065356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in human intestinal carriage of ESBL- and carbapenemase-producing Enterobacterales among food handlers in Tunisia: emergence of C1-M27-ST131 subclades, blaOXA-48 and blaNDM.
    Sallem N; Hammami A; Mnif B
    J Antimicrob Chemother; 2022 Jul; 77(8):2142-2152. PubMed ID: 35640660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
    Kim SH; Kim GR; Jeong J; Kim S; Shin JH
    Jpn J Infect Dis; 2020 Nov; 73(6):431-436. PubMed ID: 32475870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014-2018 national laboratory surveillance.
    van der Zwaluw K; Witteveen S; Wielders L; van Santen M; Landman F; de Haan A; Schouls LM; Bosch T;
    Clin Microbiol Infect; 2020 Oct; 26(10):1412.e7-1412.e12. PubMed ID: 32006688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of carbapenemase producing Enterobacterales colonization and risk factor of clinical infection.
    Lee KH; Kim D; Hong JS; Park SY; Cho NH; Kim MN; Lee YJ; Wi Y; Lee EH; Han SH; Jeong SH; Song YG
    J Infect Public Health; 2023 Nov; 16(11):1860-1869. PubMed ID: 37837922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
    Hagihara M; Kato H; Sugano T; Okade H; Sato N; Shibata Y; Sakanashi D; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Mikamo H
    Int J Antimicrob Agents; 2021 May; 57(5):106330. PubMed ID: 33789129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.